Bell Michael Brian 4

4 · Guardant Health, Inc. · Filed Dec 17, 2025

Form 4

Period: 2025-12-15

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-12-15+1,233→ 29,285 total
Exercise/Conversion
Common Stock
2025-12-15+2,039→ 31,324 total
Tax Payment
Common Stock
2025-12-15$102.67/sh−1,659$170,330→ 29,665 total
Exercise/Conversion
Restricted Stock Units
2025-12-15−1,233→ 1,233 total
Exercise: $0.00→ Common Stock (1,233 underlying)
Exercise/Conversion
Restricted Stock Units
2025-12-15−2,039→ 4,078 total
Exercise: $0.00→ Common Stock (2,039 underlying)

Footnotes (4)

[F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
[F2]This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
[F3]Not applicable for Restricted Stock Units.
[F4]This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Documents

1 file